Dr. Monés, Medical Director of the Barcelona Macula Foundation: Research for Vision (BMF), will give a talk at the National Institute of Health (NIH) in Bethesda, Maryland at 11am today, Wednesday 19 February.
Under the title “Subtle details in Inconclusion Criteria May Be the Key for Success of Clinical Trials for Chronic Conditions”, Dr. Jordi Monés will expound his knowledge and experience in clinical research through examples based on cases of Age-Related Macular Degeneration (AMD).
Dr. Jordi Monés’s address will include an explanation of the importance of individual assessment of the rate geographic atrophy is produced in AMD. This enables greater accuracy to be obtained in prognosis and better definition of eligibility criteria in the evaluation of the efficacy results of clinical trials.
The NIH forms part of the United States Department of Health and Human Services. It comprises 27 institutes and public research centres interested in the country’s health. These periodically invite professionals and recognised international experts on different medical specialities to provide a more detailed vision of the pathologies that most concern their field. On this occasion, the NIH has issued Dr. Monés with an invitation.
Image: Dr Monés with Dr Deborah Carper Ph.D. Deputy Director and Dr Gyan “John” Prakash, Ph.D., MBA Associate Director, International Programs of the National Eye Institute National (National Institutes of Health)